X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1260) 1260
Publication (105) 105
Book Chapter (16) 16
Book Review (15) 15
Conference Proceeding (6) 6
Dissertation (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
deferiprone (1121) 1121
humans (675) 675
deferoxamine (492) 492
index medicus (452) 452
male (369) 369
iron chelating agents - therapeutic use (352) 352
hematology (347) 347
female (301) 301
desferrioxamine (293) 293
thalassemia (291) 291
beta-thalassemia (286) 286
iron (278) 278
pyridones - therapeutic use (272) 272
adult (265) 265
iron overload (256) 256
deferasirox (237) 237
animals (207) 207
iron overload - drug therapy (200) 200
iron - metabolism (199) 199
deferoxamine - therapeutic use (192) 192
overload (189) 189
adolescent (187) 187
chelation therapy (180) 180
therapy (175) 175
thalassemia major (170) 170
child (162) 162
biochemistry & molecular biology (160) 160
beta-thalassemia - drug therapy (153) 153
iron chelating agents - administration & dosage (140) 140
iron chelating agents - adverse effects (133) 133
iron chelating agents - pharmacology (132) 132
pharmacology & pharmacy (129) 129
pyridones - administration & dosage (127) 127
pyridones - pharmacology (122) 122
chelation (117) 117
safety (112) 112
drug therapy, combination (111) 111
pyridones - adverse effects (111) 111
iron overload - etiology (108) 108
middle aged (106) 106
ferritins - blood (104) 104
survival (102) 102
myocardial iron (100) 100
iron chelation (99) 99
magnetic resonance imaging (96) 96
treatment outcome (96) 96
beta-thalassemia - complications (95) 95
administration, oral (94) 94
rats (93) 93
toxicity (89) 89
thalassaemia (87) 87
beta-thalassemia major (86) 86
magnetic-resonance (86) 86
blood transfusion (85) 85
efficacy (85) 85
chelation-therapy (83) 83
oxidative stress (83) 83
ferritin (81) 81
transfusion reaction (81) 81
deferoxamine - administration & dosage (80) 80
thalassemia - drug therapy (80) 80
benzoates - therapeutic use (78) 78
complications (78) 78
iron chelators (78) 78
triazoles - therapeutic use (78) 78
medicine, general & internal (77) 77
beta-thalassemia - therapy (76) 76
transfusion (74) 74
young adult (74) 74
trial (72) 72
combined therapy (71) 71
liver - metabolism (68) 68
analysis (64) 64
deferoxamine - pharmacology (63) 63
liver (63) 63
chelation therapy - methods (62) 62
mice (60) 60
child, preschool (59) 59
icl670 (59) 59
disease (58) 58
oral deferiprone (57) 57
serum ferritin (57) 57
thalassemia - therapy (57) 57
pediatrics (56) 56
deferoxamine - adverse effects (55) 55
iron overload - metabolism (55) 55
heart (54) 54
oncology (54) 54
cardiac iron (53) 53
medicine & public health (53) 53
iron chelating agents - chemistry (52) 52
myocardium - metabolism (51) 51
cardiomyopathy (50) 50
diagnosis (50) 50
1,2-dimethyl-3-hydroxypyrid-4-one (49) 49
iron - blood (49) 49
toxicology (48) 48
care and treatment (47) 47
pyridones - chemistry (47) 47
beta-thalassemia - blood (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1232) 1232
French (13) 13
German (10) 10
Spanish (7) 7
Portuguese (3) 3
Japanese (2) 2
Russian (2) 2
Arabic (1) 1
Croatian (1) 1
Czech (1) 1
Italian (1) 1
Persian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement Disorders, ISSN 0885-3185, 10/2019, Volume 34, Issue 10, pp. 1476 - 1477
Journal Article
Mutagenesis, ISSN 0267-8357, 09/2003, Volume 18, Issue 5, pp. 457 - 463
Measurements of chromosomal aberrations were made in 10 thalassaemia major patients treated long-term with deferiprone (at least 5 years) and compared with an... 
deferiprone
Journal Article
Movement Disorders, ISSN 0885-3185, 08/2011, Volume 26, Issue 9, pp. 1755 - 1759
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 10/2019, p. 112314
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 10/2018, Volume 70, Issue 10, pp. 1357 - 1368
Journal Article
Dalton Transactions, ISSN 1477-9226, 2018, Volume 47, Issue 26, pp. 8764 - 8770
Deferiprone (3-hydroxy-1,2-dimethyl-4(1H)-pyridone, DFP), which is a drug clinically used for removing heavy metals in vivo, was explored for its removal... 
URANIUM | CATECHOLATE | MECHANISM | HYDROXYPYRIDINONATE LIGANDS | DECORPORATION AGENTS | DRUG DEFERIPRONE | TOXICITY | MICE | IRON-CHELATION THERAPY | ORAL DEFERIPRONE | CHEMISTRY, INORGANIC & NUCLEAR | Water chemistry | Uranium | Structural stability | pH | X-ray diffraction | Ligands | Uranium dioxide | Crystallography | Molecular chains | Heavy metals
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 01/2019, Volume 41, Issue 1, pp. E47 - E50
An open-label, pilot study was conducted to evaluate deferasirox/deferiprone combination chelation therapy in adult patients with transfusion-dependent... 
deferiprone | iron overload | deferasirox | thalassemia | SAFETY | RISK | MYOCARDIAL IRON | DEFERIPRONE THERAPY | TRIAL | DEFEROXAMINE | ONCOLOGY | PEDIATRICS | HEMATOLOGY | Thalassemia | Usage | Care and treatment | Chelation therapy | Patient compliance | Analysis
Journal Article
Haematologica, ISSN 0390-6078, 04/2010, Volume 95, Issue 4, pp. 557 - 566
Journal Article
BioMetals, ISSN 0966-0844, 12/2018, Volume 31, Issue 6, pp. 927 - 940
Brain-derived neurotrophic factor (BDNF) plays a key role in neural development and physiology, as well as in pathological states. Post-mortem studies... 
Biochemistry, general | Microbiology | BDNF | Memory | Plant Physiology | Deferiprone | Iron | Medicine/Public Health, general | Cell Biology | Life Sciences | Catalase | Neurodegeneration | Pharmacology/Toxicology | NEURODEGENERATIVE DISORDERS | OXIDATIVE STRESS | ADULT RATS | BRAIN-INJURY | ALZHEIMERS-DISEASE | NEUROTROPHIC FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | COGNITIVE DYSFUNCTION | ANIMAL-MODELS | RECOGNITION MEMORY | PARKINSONS-DISEASE | Antioxidants - chemistry | Rats, Wistar | Rats | Brain-Derived Neurotrophic Factor - analysis | Antioxidants - pharmacology | Deferiprone - pharmacology | Hippocampus - drug effects | Iron Chelating Agents - chemistry | Deferiprone - chemistry | Animals | Memory Disorders - drug therapy | Iron Chelating Agents - pharmacology | Female | Brain-Derived Neurotrophic Factor - metabolism | Oxidative Stress - drug effects | Disease Models, Animal | Antioxidants | Medical research | Enzymes | Brain | Nervous system diseases | RNA | Developmental biology | Analysis | Physiological aspects | Medicine, Experimental | Neurophysiology | Neonates | Oxidative stress | Synaptophysin | Immunological memory | Neurodegenerative diseases | Pathogenesis | Medical services | Gene expression | Neurological diseases | Brain-derived neurotrophic factor | Autopsy | Chelation | TrkB receptors | Adults | Hippocampus | Apoptosis
Journal Article
European Journal of Haematology, ISSN 0902-4441, 08/2019, Volume 103, Issue 2, pp. 80 - 87
Objective While doses of deferiprone up to 75 mg/kg/d have been demonstrated to be effective in cardiac iron removal, their efficacy in the reduction of liver... 
deferiprone | iron overload | thalassemia | liver | chelation | MONOTHERAPY | SAFETY | RANDOMIZED CONTROLLED-TRIAL | MYOCARDIAL IRON | DEFEROXAMINE | THALASSEMIA MAJOR PATIENTS | CHELATION-THERAPY | MAGNETIC-RESONANCE | BETA-THALASSEMIA | ORAL DEFERIPRONE | HEMATOLOGY | Medicine, Experimental | Medical research | Adults | Liver | Ferritin | Heart | Hemochromatosis | Magnetic resonance imaging | Neutropenia
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2015, Volume 38, Issue 7, pp. 1076 - 1080
Endoplasmic reticulum stress has been reported to be involved in the pathogenesis of retinitis pigmentosa, macular degeneration and diabetic retinopathy. In... 
Journal Article
CIRCULATION, ISSN 0009-7322, 11/2009, Volume 120, Issue 20, pp. 1961 - U23
Background-The goal of this study was to determine the predictive value of cardiac T2* magnetic resonance for heart failure and arrhythmia in thalassemia... 
SURVIVAL | iron overload | DIAGNOSIS | magnetic resonance imaging | CARDIAC & CARDIOVASCULAR SYSTEMS | thalassemia | CARDIOVASCULAR MAGNETIC-RESONANCE | CARDIOMYOPATHY | heart | DEFEROXAMINE | siderosis | TRANSFUSION | MYOCARDIAL IRON OVERLOAD | PERIPHERAL VASCULAR DISEASE | BETA-THALASSEMIA | HEMATOLOGY | DEFERIPRONE
Journal Article